Synthetic warehouse · not for clinical use
Watchdog JSON
Pattern layer · privacy-safe aggregates

Data patterns

Command center

Profiles are versioned counts, quantiles, and transition rates. These atlases are synthetic, so every category is kept by name. A source flagged real or sensitive suppresses cells under 11. No source row is stored.

Profiles
51
6 sources · synthetic k = 0
Fidelity checks
14/14
JS, KS, and the atlas rules
Challenges
8
Tagged with strategy and confidence
Insight rows
423,232
Generated at each release’s cohort ratio

clinical

ProfileVersionRows learnedSampledLeading pattern
clinical.adverse_eventv2504504moderate 54% · mild 46%
clinical.encounterv242,70142,701outpatient 100%

commercial

ProfileVersionRows learnedSampledLeading pattern
commercial.touchpointv2919919video 27% · approved_email 26% · field 24% · webinar 23%

distribution

ProfileVersionRows learnedSampledLeading pattern
distribution.inventory_ledgerv219,69919,699DISPENSE 65% · SHIPMENT_IN 22% · OPENING 13%

insight

ProfileVersionRows learnedSampledLeading pattern
insight.attitude_trackersv2276,000276,0002025-01 4% · 2025-02 4% · 2025-03 4% · 2025-04 4%
insight.community_pollsv21,8471,847Identifiers and measures only
insight.community_postsv224,00024,000Case discussion 23% · Discussion 23% · Peer insight 23% · Question 22%
insight.content_moderationv2439439Unsubstantiated clinical claim 36% · Possible personal information 33% · Off topic 32%
insight.data_provenancev277professionals 14% · synthetic_drugs 14% · drug_ratings 14% · survey_answers 14%
insight.drug_ratingsv294,00094,0001-5 years 33% · 6-10 years 33% · 11+ years 33%
insight.identity_crosswalkv212,00012,000deterministic_synthetic_id 100%
insight.member_connectionsv223,00023,000Follow 100%
insight.member_incentivesv253,48953,489Paid 97% · Approved 3%
insight.member_interestsv223,92523,925Identifiers and measures only
insight.member_profilesv212,00012,000Active 94% · Dormant 6%
insight.member_sessionsv258,00058,000Mobile 65% · Desktop 30% · Tablet 5%
insight.metadatav299product 11% · version 11% · generated_on 11% · synthetic 11%
insight.panel_participantsv2400400Attended 77% · No show 15% · Waitlist 8%
insight.poll_optionsv27,3887,388Identifiers and measures only
insight.poll_responsesv248,69848,698Identifiers and measures only
insight.post_commentsv262,00062,000Approved 100%
insight.post_reactionsv2125,000125,000Like 40% · Helpful 25% · Insightful 20% · Agree 15%
insight.professionalsv212,00012,000Physician 94% · Physician assistant 2% · Pharmacist 2% · Nurse 1%
insight.qualitative_panelsv25050Online bulletin board 46% · Video interview 28% · Online focus group 26%
insight.quality_checksv266foreign_keys 17% · members_have_professional 17% · rating_bounds 17% · synthetic_professionals 17%
insight.research_clientsv24242Fictional Research Sponsor 001 2% · Fictional Research Sponsor 002 2% · Fictional Research Sponsor 003 2% · Fictional Research Sponsor 004 2%
insight.research_invitationsv2143,514143,514Email digest 35% · Survey invitation 35% · App feed 15% · Community notification 10%
insight.research_studiesv2380380Quantitative 54% · Rapid pulse 23% · Longitudinal ATU 17% · Qualitative 6%
insight.specialtiesv22424Family Medicine 4% · Internal Medicine 4% · Cardiology 4% · Medical Oncology 4%
insight.study_participationv267,37767,377Complete 79% · Quota full 7% · Abandoned 7% · Partial 7%
insight.study_quotasv2760760Profession 100%
insight.survey_answersv2267,445267,445Identifiers and measures only
insight.survey_questionsv21,9001,900Often|Sometimes|Rarely|Never 20% · Efficacy|Safety|Access|Adherence 20%
insight.survey_screenersv278,47678,476Quota full 5% · Insufficient patient volume 5% · Practice setting not qualified 5%
insight.synthetic_drugsv2120120Fictional Therapy 001 1% · Fictional Therapy 002 1% · Fictional Therapy 003 1% · Fictional Therapy 004 1%
insight.therapeutic_areasv21212Oncology 8% · Cardiovascular 8% · Diabetes 8% · Immunology 8%
insight.topicsv21212Clinical practice 8% · Treatment sequencing 8% · Payer restrictions 8% · Emerging evidence 8%
insight.treatment_patternsv296,00096,0002025-01 13% · 2025-04 13% · 2025-07 13% · 2025-10 13%
insight.verification_eventsv212,00012,000Synthetic license confirmation 100%

patient

ProfileVersionRows learnedSampledLeading pattern
patient.journey_eventv272,71472,714PRESCRIPTION_ORDER 42% · ACCESS_FAILURE 24% · DISPENSED 18% · DIAGNOSIS 17%
patient.journey_transitionsv260,71460,714Identifiers and measures only
patient.treatment_episodev29,8879,887new_therapy 86% · switch 14%

rx

ProfileVersionRows learnedSampledLeading pattern
rx.claim_attemptv238,57838,578B1 100%
rx.drugv26969DERM 17% · ONC 17% · RESP 16% · MHEALTH 14%
rx.formulary_at_orderv230,35730,357Covered 59% · Not covered 41%
rx.hcov21,1891,189Multi-specialty Group 22% · Primary Care Group 22% · Hospital 11% · Ambulatory Surgery Center 9%
rx.hcpv21,5001,500FM 13% · IM 9% · CARD 7% · NP 6%
rx.orders_per_patientv212,00012,000Identifiers and measures only
rx.patientv212,00012,000F 51% · M 49%
rx.planv2240240Commercial 30% · Medicare Advantage-PD 23% · Medicaid Managed Care 13% · Exchange 12%
rx.prescription_orderv230,35730,357ISSUED 100%

Fidelity against the learned profile

Each golden release is scored against the atlas profile. A later version that moves past a threshold is a drift, not a silent rewrite.

ReleaseTableMetricScoreThresholdGate
nsclc-metex14_1.0drugjs_ta_code0.0320.22pass
nsclc-metex14_1.0formularyjs_coverage0.0000.08pass
nsclc-metex14_1.0hcpjs_specialty0.0020.12pass
nsclc-metex14_1.0hcpjs_state0.0020.12pass
nsclc-metex14_1.0journeysequence_violation0.0000.05pass
nsclc-metex14_1.0patientks_birth_year0.0440.35pass
nsclc-metex14_1.0planjs_channel0.0030.12pass
psoriasis-biologics_1.0drugjs_ta_code0.0320.22pass
psoriasis-biologics_1.0formularyjs_coverage0.0000.08pass
psoriasis-biologics_1.0hcpjs_specialty0.0020.12pass
psoriasis-biologics_1.0hcpjs_state0.0020.12pass
psoriasis-biologics_1.0journeysequence_violation0.0000.05pass
psoriasis-biologics_1.0patientks_birth_year0.0440.35pass
psoriasis-biologics_1.0planjs_channel0.0030.12pass

Drift across versions

rel_nsclc-metex14_1.0 · 7 checks · widest distance 0.044

rel_psoriasis-biologics_1.0 · 7 checks · widest distance 0.044

Version 1 is the baseline learned from the released atlas files on 2026-11-20. The next hive run profiles the new release and compares it with this baseline.

Insight atlas, at release scale

ReleaseTableLearnedGeneratedRatio
nsclcattitude_trackers276,00055,2000.20
nsclcsurvey_answers267,44553,4890.20
nsclcresearch_invitations143,51428,7030.20
nsclcpost_reactions125,00025,0000.20
nsclctreatment_patterns96,00019,2000.20
nsclcdrug_ratings94,00018,8000.20
nsclcsurvey_screeners78,47615,6950.20
nsclcstudy_participation67,37713,4750.20
nsclcpost_comments62,00012,4000.20
nsclcmember_sessions58,00011,6000.20
nsclcmember_incentives53,48910,6980.20
nsclcpoll_responses48,6989,7400.20
nsclccommunity_posts24,0004,8000.20
nsclcmember_interests23,9254,7850.20
nsclcmember_connections23,0004,6000.20
nsclcprofessionals12,0002,4000.20
nsclcidentity_crosswalk12,0002,4000.20
nsclcmember_profiles12,0002,4000.20
nsclcverification_events12,0002,4000.20
nsclcpoll_options7,3881,4780.20
nsclccontent_moderation4394391.00
nsclcpanel_participants4004001.00
nsclcresearch_studies3803801.00
nsclcsurvey_questions1,9003800.20
nsclccommunity_polls1,8473690.20
nsclcstudy_quotas7601520.20
nsclcsynthetic_drugs1201201.00
nsclcqualitative_panels50501.00
nsclcresearch_clients42421.00
nsclcspecialties24241.00
nsclctopics12121.00
nsclctherapeutic_areas12121.00
nsclcmetadata991.00
nsclcdata_provenance771.00
nsclcquality_checks661.00
psoriasisattitude_trackers276,00022,0800.08
psoriasissurvey_answers267,44521,3960.08
psoriasisresearch_invitations143,51411,4810.08
psoriasispost_reactions125,00010,0000.08
psoriasistreatment_patterns96,0007,6800.08
psoriasisdrug_ratings94,0007,5200.08
psoriasissurvey_screeners78,4766,2780.08
psoriasisstudy_participation67,3775,3900.08
psoriasispost_comments62,0004,9600.08
psoriasismember_sessions58,0004,6400.08
psoriasismember_incentives53,4894,2790.08
psoriasispoll_responses48,6983,8960.08
psoriasiscommunity_posts24,0001,9200.08
psoriasismember_interests23,9251,9140.08
psoriasismember_connections23,0001,8400.08
psoriasisprofessionals12,0009600.08
psoriasismember_profiles12,0009600.08
psoriasisidentity_crosswalk12,0009600.08
psoriasisverification_events12,0009600.08
psoriasispoll_options7,3885910.08
psoriasiscontent_moderation4394391.00
psoriasispanel_participants4004001.00
psoriasisresearch_studies3803801.00
psoriasissurvey_questions1,9001520.08
psoriasiscommunity_polls1,8471480.08
psoriasissynthetic_drugs1201201.00
psoriasisstudy_quotas760610.08
psoriasisqualitative_panels50501.00
psoriasisresearch_clients42421.00
psoriasisspecialties24241.00
psoriasistopics12121.00
psoriasistherapeutic_areas12121.00
psoriasismetadata991.00
psoriasisdata_provenance771.00
psoriasisquality_checks661.00